Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call. At this time all participants are in a listen-only mode. The floor will be opened for ...

Cash and Equivalents (End of 2024): $228 million, with no debt. Progyny Inc (NASDAQ:PGNY) reported revenue and adjusted EBITDA for the fourth quarter above the high end of their guidance ranges.

Progyny, Inc. ((PGNY)) has held its Q4 earnings call. Read on for the main highlights of the call. See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze ...

and issue a press release regarding its financial results prior to the start of the call. In Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected ...

The market expects Progyny (PGNY) to deliver a year-over-year increase in earnings on higher revenues ... of business conditions on theearnings call it's worth handicapping the probability of ...

Shares of NASDAQ PGNY opened at $23.20 on Monday ... The stock has a market cap of $1.98 billion, a PE ratio of 40.00, a price-to-earnings-growth ratio of 2.39 and a beta of 1.34.

Progyny Inc. (PGNY) on Thursday reported fourth-quarter net income of $10.5 million. On a per-share basis, the New York-based company said it had net income of 12 cents. Earnings, adjusted for one ...

Progyny Inc . (NASDAQ:PGNY) reported strong financial results for Q4 2024, significantly surpassing earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.42, ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers. Upfront premiums collected by health ...

Cash and Equivalents (End of 2024): $228 million, with no debt. Progyny Inc (NASDAQ:PGNY) reported revenue and adjusted EBITDA for the fourth quarter above the high end of their guidance ranges. The ...